MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis
Liangyou Gu(Chinese PLA General Hospital), Xu Zhang(Beijing Solar Energy Research Institute), Yu Zhang(Wannan Medical College), Fan Yang(Nantong University), Xintao Li(Shanghai Jiao Tong University), Luyao Chen(Chinese PLA General Hospital), Hongzhao Li(Canadian Food Inspection Agency), Yu Gao(Chinese PLA General Hospital), Xin Ma(Chinese PLA General Hospital)
Cited by 104
Related Papers
Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium
|Stem Cell Research & Therapy|2019|294
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
|Cancer Letters|2008|216
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
|Annals of Oncology|2021|212